PunjiPUNJI
Pharmaceuticals & BiotechnologySmall Cap

Wanbury Limited

WANBURY · ISIN: INE107F01022

Wanbury Limited is a small cap company in the Pharmaceuticals & Biotechnology sector, listed on the NSE under ISIN INE107F01022.

Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.

Close (as of 2026-10-29)
₹181.93
+4.46% today
Day Range
₹172.63 - ₹185.01
Market Cap (Small Cap)
₹636.153 Cr
Quality Score (as of 2026-06-30)
50/100

Price History

CHART

Wanbury Limited - growth of ₹100

Growth of ₹100 invested on 2026-05-08, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.

-1326661051442026-05-082026-07-172026-08-122026-08-262026-09-092026-09-242026-10-092026-10-262026-10-29

1M

-8.81%

3M

-38.02%

6M

-28.45%

1Y

-22.68%

3Y CAGR

+25.38%

5Y CAGR

-

Earnings (TTM)

LEARN: Revenue and PAT · EPS · P/E

CHART

Wanbury Limited - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr184 Cr368 Cr553 Cr737 CrQ3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

-

EBITDA Margin (TTM)

Technicals

Not available for this stock yet.

Shareholding Pattern

Not available for this stock yet.

Corporate Actions

No corporate actions on record for this stock.

Recent Deals

DateTypeQuantity
2026-10-06BULK1,97,146

Frequently asked questions

What is Wanbury Limited's 1-year and 3-year return?

Wanbury Limited's 1-year price return is -22.68%. Its 3-year CAGR (annualized return) is +25.38%. Both are price-only returns (no dividends added back), computed from the nearest available trading day to each anniversary - not a forecast of future performance.

What is Wanbury Limited's latest financial performance?

Wanbury Limited's trailing-twelve-month (TTM) revenue as of 2026-06-30 is ₹653 Cr, with a TTM profit after tax of ₹56 Cr and an EBITDA margin of null%. TTM figures sum the most recent four reported quarters rather than a single quarter, which smooths out seasonal swings in a business's revenue and profit. EPS (earnings per share) over this TTM window is ₹17.36.

What is Wanbury Limited's quality score?

Wanbury Limited has a Punji quality score of 50 out of 100 as of 2026-06-30. This composite score is computed from the company's reported fundamentals (profitability, balance-sheet strength, and consistency of earnings, among other factors) and is designed to be comparable across companies in different sectors. A higher score indicates a fundamentally stronger business by these measures, though it isn't a price target or a buy/sell signal - a high-quality company can still be expensively priced, and a lower-scoring one can still be a reasonable investment at the right valuation.

Has Wanbury Limited seen any recent bulk or block deals?

Yes, as of 2026-10-06 - the most recent recorded deal was a BULK on 2026-10-06 for 1,97,146 shares. Bulk and block deals are large trades (above exchange-defined thresholds) that must be publicly disclosed, and are often watched as a signal of institutional or high-net-worth investor conviction - though a single deal doesn't establish a trend, and the counterparty's reasons for buying or selling aren't disclosed alongside the trade itself.

Stock data · Not financial advice · Past performance does not indicate future returns